Cong Xu
Private Equity Investor bei LAV Management Co., Ltd.
Aktive Positionen von Cong Xu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
LAV Management Co., Ltd.
 LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Private Equity Investor | 01.01.2018 | - |
Karriereverlauf von Cong Xu
Ehemalige bekannte Positionen von Cong Xu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
IMPACT Therapeutics, Inc.
 IMPACT Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology IMPACT Therapeutics, Inc. manufactures pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China. | Präsident | 01.01.2018 | 01.12.2019 |
Ausbildung von Cong Xu
| University of British Columbia | Masters Business Admin |
| Clemson University | Graduate Degree |
Statistik
International
| China | 3 |
| Kanada | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Private Equity Investor | 1 |
| President | 1 |
| Masters Business Admin | 1 |
Sektoral
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
IMPACT Therapeutics, Inc.
IMPACT Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology IMPACT Therapeutics, Inc. manufactures pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China. | Health Technology |
